Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 790,000 | 531,000 | 235,000 | 921,000 | 685,000 |
| Depreciation Amortization | 425,000 | 283,000 | 140,000 | 493,000 | 358,000 |
| Income taxes - deferred | 118,000 | 8,000 | 7,000 | 13,000 | -21,000 |
| Accounts receivable | -153,000 | -115,000 | -101,000 | -71,000 | -140,000 |
| Other Working Capital | -14,000 | -35,000 | -90,000 | -201,000 | -234,000 |
| Other Operating Activity | 255,000 | 186,000 | 123,000 | 179,000 | 222,000 |
| Operating Cash Flow | $1,421,000 | $858,000 | $314,000 | $1,334,000 | $870,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -369,000 | -225,000 | -117,000 | -425,000 | -302,000 |
| Net Acquisitions | -51,000 | -17,000 | N/A | -2,164,000 | -1,781,000 |
| Other Investing Activity | -20,000 | 3,000 | 2,000 | 41,000 | 37,000 |
| Investing Cash Flow | $-440,000 | $-239,000 | $-115,000 | $-2,548,000 | $-2,046,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 410,000 | 400,000 | 215,000 | 1,846,000 | 1,846,000 |
| Debt Repayment | -1,011,000 | -1,001,000 | -600,000 | -303,000 | -302,000 |
| Common Stock Issued | 61,000 | 42,000 | 29,000 | 73,000 | 52,000 |
| Common Stock Repurchased | -150,000 | N/A | N/A | -151,000 | 0 |
| Dividend Paid | -306,000 | -203,000 | -102,000 | -378,000 | -282,000 |
| Other Financing Activity | -105,000 | -92,000 | -103,000 | -3,000 | -60,000 |
| Financing Cash Flow | $-1,101,000 | $-854,000 | $-561,000 | $1,084,000 | $1,254,000 |
| Exchange Rate Effect | 3,000 | 5,000 | 1,000 | -7,000 | N/A |
| Beginning Cash Position | 549,000 | 549,000 | 549,000 | 686,000 | 686,000 |
| End Cash Position | 432,000 | 319,000 | 188,000 | 549,000 | 764,000 |
| Net Cash Flow | $-117,000 | $-230,000 | $-361,000 | $-137,000 | $78,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,421,000 | 858,000 | 314,000 | 1,334,000 | 870,000 |
| Capital Expenditure | -369,000 | -225,000 | -117,000 | -425,000 | -302,000 |
| Free Cash Flow | 1,052,000 | 633,000 | 197,000 | 909,000 | 568,000 |